Inventor
ORRIN DEVINSKY
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations46%
B01DSeparation8%
PatentTitleYear
12,427,160Use of cannabinoids in the treatment of epilepsy202512,318,356Use of cannabinoids in the treatment of epilepsy202512,064,399Use of cannabinoids in the treatment of epilepsy202411,963,937Use of cannabinoids in the treatment of epilepsy202411,766,411Use of cannabinoids in the treatment of epilepsy202311,701,330Use of cannabinoids in the treatment of epilepsy202311,633,369Use of cannabinoids in the treatment of epilepsy202311,446,258Use of cannabinoids in the treatment of epilepsy202211,357,741Use of cannabinoids in the treatment of epilepsy202211,311,498Use of cannabinoids in the treatment of epilepsy202211,154,516Use of cannabinoids in the treatment of epilepsy202111,154,517Use of cannabinoids in the treatment of epilepsy2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to GW RES LTD (9)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to GW PHARMA LTD (1)· patent assignee history
2024–2025Patents assigned to JAZZ PHARMACEUTICALS RESEARCH UK LTD (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GW RES LTD | 9 | 2021–2024 |
| JAZZ PHARMACEUTICALS RESEARCH UK LTD | 3 | 2024–2025 |
| GW PHARMA LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2021–2025 |